Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07364851
PHASE1
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers
Sponsor: Daewon Pharmaceutical Co., Ltd.
View on ClinicalTrials.gov
Summary
Safety and pharmacokinetic characteristics evaluation of DW4421-T1 and DW4421S-T1
Official title: A Randomized, Open-label, Single-dose, 2-sequence, Two-period, Crossover Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics After Administration of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
38
Start Date
2026-03-06
Completion Date
2026-08-30
Last Updated
2026-01-23
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
DW4421-T1
DW4421-T1 or DW4421S-T1
DRUG
DW4421S-T1
DW4421-T1 or DW4421S-T1
Locations (1)
Chungbuk National University Hospital
Cheongju-si, South Korea